nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.11.2012 | Original Paper

Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer

verfasst von: Yi-Peng Tao, Wan-Ling Wang, Song-Yue Li, Jian Zhang, Qi-Zhong Shi, Fen Zhao, Bao-Sheng Zhao

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to investigate whether IL-12A, IL-12B, IL-12Rβ1, and IL-27 gene polymorphisms and serum levels of IL-12, IL-27 are associated with esophageal cancer.

Methods

We genotyped IL-12A gene rs568408, IL-12B gene rs3212227, IL-12Rβ1 gene 378 C/G, IL-27 gene rs153109, rs17855750, and rs181206 polymorphisms in a case–control study of 426 esophageal cancer patients and 432 health controls, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and serum IL-12p40 and IL-27p28 levels were measured by enzyme-linked immunosorbent assay.

Results

Both serum IL-12p40 and IL-27p28 levels were significantly higher in controls than those in patients (P < 0.01). Rs568408 AG/AA, rs3212227 CC/AC, and IL-12Rβ1 378 GG/GC genotypes were associated with significantly increased risk of esophageal cancer (rs568408: χ² = 5.704, P = 0.017; rs3212227: χ² = 7.689, P = 0.006; IL-12Rβ1 378C/G: χ² = 5.206, P = 0.023). Moreover, rs3212227 CC/AC and 378 GG/GC genotypes were observed significantly associated with decreased serum IL-12p40 level in patients compare to other genotypes (rs3212227: t = 2.129, P = 0.034; IL-12Rβ1 378 C/G: t = 2.178, P = 0.030). Furthermore, frequency of rs3212227 CC/AC genotypes was significantly higher in patients with poor differentiation than those with AA genotype (χ² = 4.314, P = 0.035).

Conclusion

Our data suggest that the impaired production of IL-12p40 and IL-27p28 behaves as risk factors for esophageal cancer occurrence. IL-12B gene rs3212227 CC/AC and IL-12Rβ1 gene 378 GG/GC genotypes, which associated with decreased IL-12p40 level, may contribute to esophageal cancer susceptibility.

Chae SC, Li CS, Kim KM, Yang JY, Zhang Q, Lee YC, Yang YS, Chung HT (2007) Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J Hum Genet 52(4):355–361CrossRefPubMed

Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, Shi X, Qian N, Wang X, Wei Q, Shen H, Hu Z (2009) Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res 15(1):400–405CrossRefPubMed

Chiyo M, Shimozato O, Yu L, Kawamura K, Iizasa T, Fujisawa T, Tagawa M (2005) Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 115(3):437–442CrossRefPubMed

Cordoba-Rodriguez R, Frucht DM (2003) IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics. Expert Opin Biol Ther 3(5):715–723CrossRefPubMed

Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13(16):4677–4685CrossRefPubMed

Emoto Y, Yoshizawa I, Hurwitz R, Brinkmann V, Kaufmann SH, Emoto M (2008) Role of interleukin-12 in determining differential kinetics of invariant natural killer T cells in response to differential burden of Listeria monocytogenes. Microbes Infect 10(3):224–232CrossRefPubMed

Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D, Kaklamani E, Moutsopoulos H, Loughran TP Jr, Ollier WE, Panayi GS, Lanchbury JS (2000) Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 1(3):219–224CrossRefPubMed

He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK (2005) Major causes of death among men and women in China. N Engl J Med 353(11):1124–1134CrossRefPubMed

He XZ, Wang L, Zhang YY (2008) An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells. World J Gastroenterol 14(4):532–540CrossRefPubMed

Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romani N, Schuler G (1996) Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 26(3):659–668CrossRefPubMed

Holmes RS, Vaughan TL (2007) Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 17(1):2–9CrossRefPubMed

Holscher C, Holscher A, Ruckerl D, Yoshimoto T, Yoshida H, Mak T, Saris C, Ehlers S (2005) The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174(6):3534–3544PubMed

Horinaga M, Harsch KM, Fukuyama R, Heston W, Larchian W (2005) Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model. Urology 66(2):461–466CrossRefPubMed

Hsieh YY, Chang CC, Tsai CH, Lin CC, Tsai FJ (2007) Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3′-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. Fertil Steril 87(4):886–895CrossRefPubMed

Huang D, Cancilla MR, Morahan G (2000) Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun 1(8):515–520CrossRefPubMed

Hunter CA (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5(7):521–531CrossRefPubMed

Hussein MZ, Al Fikky A, Abdel Bar I, Attia O (2004) Serum IL-6 and IL-12 levels in breast cancer patients. Egypt J Immunol 11(2):165–170PubMed

Kennon B, Ingram MC, Friel EC, Anderson NH, MacKenzie SM, Davies E, Shakerdi L, Wallace AM, Fraser R, Connell JM (2004) Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clin Endocrinol (Oxf) 61(2):174–181CrossRef

Lee KM, Shen M, Chapman RS, Yeager M, Welch R, He X, Zheng T, Hosgood HD, Yang D, Berndt SI, Chanock S, Lan Q (2007) Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 28(7):1437–1441CrossRefPubMed

Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117(5):1175–1183CrossRefPubMed

Liu L, Xu Y, Liu Z, Chen J, Zhang Y, Zhu J, Liu J, Liu S, Ji G, Shi H, Shen H, Hu Z (2011) IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population. Int J Cancer 128(7):1692–1696CrossRefPubMed

Miteva L, Stanilov N, Deliysky T, Mintchev N, Stanilova S (2009) Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer. Cancer Invest 27(9):924–931CrossRefPubMed

Murakami S, Okubo K, Tsuji Y, Sakata H, Hamada S, Hirayama R (2004) Serum interleukin-12 levels in patients with gastric cancer. Surg Today 34(12):1014–1019CrossRefPubMed

Owaki T, Asakawa M, Morishima N, Hata K, Fukai F, Matsui M, Mizuguchi J, Yoshimoto T (2005) A role for IL-27 in early regulation of Th1 differentiation. J Immunol 175(4):2191–2200PubMed

Sangro B, Melero I, Qian C, Prieto J (2005) Gene therapy of cancer based on interleukin 12. Curr Gene Ther 5(6):573–581CrossRefPubMed

Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286(24):3106–3114CrossRefPubMed

Shimizu M, Shimamura M, Owaki T, Asakawa M, Fujita K, Kudo M, Iwakura Y, Takeda Y, Luster AD, Mizuguchi J, Yoshimoto T (2006) Antiangiogenic and antitumor activities of IL-27. J Immunol 176(12):7317–7324PubMed

Shirasawa S, Harada H, Furugaki K, Akamizu T, Ishikawa N, Ito K, Tamai H, Kuma K, Kubota S, Hiratani H, Tsuchiya T, Baba I, Ishikawa M, Tanaka M, Sakai K, Aoki M, Yamamoto K, Sasazuki T (2004) SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum Mol Genet 13(19):2221–2231CrossRefPubMed

Stanilova S, Miteva L, Prakova G (2007) Interleukin-12B-3′UTR polymorphism in association with IL-12p40 and IL-12p70 serum levels and silicosis severity. Int J Immunogenet 34(3):193–199CrossRefPubMed

Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3(2):133–146CrossRefPubMed

Villarino AV, Huang E, Hunter CA (2004) Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 173(2):715–720PubMed

Wei YS, Lan Y, Luo B, Lu D, Nong HB (2009) Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinog 48(8):751–757CrossRefPubMed

Windsor L, Morahan G, Huang D, McCann V, Jones T, James I, Christiansen FT, Price P (2004) Alleles of the IL12B 3′UTR associate with late onset of type 1 diabetes. Hum Immunol 65(12):1432–1436CrossRefPubMed

You TG, Wang HS, Yang JH, Qian QJ, Fan RF, Wu MC (2004) Transfection of IL-2 and/or IL-12 genes into spleen in treatment of rat liver cancer. World J Gastroenterol 10(15):2190–2194PubMed

Zabala M, Lasarte JJ, Perret C, Sola J, Berraondo P, Alfaro M, Larrea E, Prieto J, Kramer MG (2007) Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer. J Hepatol 47(6):807–815CrossRefPubMed

Zhao B, Meng LQ, Huang HN, Pan Y, Xu QQ (2009) A novel functional polymorphism, 16974 A/C, in the interleukin-12-3′ untranslated region is associated with risk of glioma. DNA Cell Biol 28(7):335–341CrossRefPubMed

Titel: Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer
verfasst von: Yi-Peng Tao
Wan-Ling Wang
Song-Yue Li
Jian Zhang
Qi-Zhong Shi
Fen Zhao
Bao-Sheng Zhao
Publikationsdatum: 01.11.2012
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2012
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-012-1269-0

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2012

Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib

HIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosis

UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer

MicroRNA expression analysis of mammospheres cultured from human breast cancers

DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia

Preliminary results of intensity-modulated radiation therapy with helical tomotherapy for prostate cancer

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie